本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或 者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 证券代码：605167 证券简称：利柏特 公告编号：2025-017 江苏利柏特股份有限公司 2024年年度权益分派实施公告 每股分配比例 A 股每股现金红利0.113元（含税） 相关日期 | 股份类别 | 股权登记日 | 最后交易日 | 除权（息）日 | 现金红利发放日 | | --- | --- | --- | --- | --- | | Ａ股 | 2025/6/11 | － | 2025/6/12 | 2025/6/12 | 差异化分红送转： 是 一、 通过分配方案的股东大会届次和日期 本次利润分配方案经公司2025 年 5 月 20 日的2024年年度股东大会审议通过。 二、 分配方案 截至股权登记日下午上海证券交易所收市后，在中国证券登记结算有限责任公司上海分 公司（以下简称"中国结算上海分公司"）登记在册的本公司全体股东。 根据《上海证券交易所上市公司自律监管指引第 7 号——回购股份》的规定，公司回购 专用证券账户中的股份 5,154,000 股不参 ...

Group 1 - The nuclear power sector experienced a significant rally on the 28th, with stocks such as Jiusheng Electric rising over 16% and Tianli Composite increasing by more than 13%, reaching new highs [1] - Notably, Rongfa Nuclear Power has seen a consecutive four-day limit-up, while Changcheng Electric and Huijin Tong achieved three consecutive limit-ups [1] - Changcheng Electric confirmed that its production and operations are normal, with no significant changes in market conditions or industry policies, although it still expects a net loss for 2024 compared to the previous year [1] Group 2 - Zhejiang Securities believes that Trump's new policies will further strengthen the global nuclear power development narrative, leading to increased capital expenditure in the industry [2] - As a direct fuel source for existing nuclear power technology, the demand for natural uranium is expected to grow alongside the expansion of the U.S. nuclear energy scale and the promotion of Small Modular Reactors (SMRs) [2] - The supply-demand imbalance for natural uranium, which has been alleviated in recent years, is anticipated to become more pronounced over time, driving up uranium prices and establishing a long-term bullish trend [2]

上海市锦天城律师事务所 关于江苏利柏特股份有限公司 2024 年年度股东会的 法律意见书 地址：上海市浦东新区银城中路 501 号上海中心大厦 9/11/12 层 电话: 021-20511000 邮编：200120 上海市锦天城律师事务所 法律意见书 上海市锦天城律师事务所 关于江苏利柏特股份有限公司 锦 天 城 律 师事 务 所 ALLBRIGHT LAW OFFICES 2024 年年度股东会的 法律意见书 致:江苏利柏特股份有限公司 上海市锦天城律师事务所(以下简称"本所")接受江苏利柏特股份有限公司 (以下简称"公司")委托,就公司召开 2024年年度股东会(以下简称"本次股 东会")的有关事宜,根据《中华人民共和国公司法》(以下简称《公司法》)《上 市公司股东会规则》等法律、法规和其他规范性文件以及《江苏利柏特股份有限 公司章程》(以下简称《公司章程》)的有关规定,出具本法律意见书。 为出具本法律意见书,本所及本所律师依据《律师事务所从事证券法律业务 管理办法》和《律师事务所证券法律业务执业规则》等规定,严格履行了法定职 责,遵循了勤勉尽责和诚实信用原则,对本次股东会所涉及的相关事项进行了必 要的 ...

证券代码：605167 证券简称：利柏特 公告编号：2025-016 江苏利柏特股份有限公司 2024年年度股东会决议公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 本次会议是否有否决议案：无 络投票相结合的表决方式。本次会议的召集、召开程序、出席会议人员的资格、 会议召集人资格、会议表决程序和表决结果均符合《公司法》及《公司章程》的 有关规定。 (五)公司董事、监事和董事会秘书的出席情况 二、 议案审议情况 (一)非累积投票议案 一、 会议召开和出席情况 (一)股东会召开的时间：2025 年 5 月 20 日 (二)股东会召开的地点：江苏省张家港江苏扬子江重型装备产业园沿江公路 2667 号公司会议室 (三)出席会议的普通股股东和恢复表决权的优先股股东及其持有股份情况： | 1、出席会议的股东和代理人人数 | 134 | | --- | --- | | 2、出席会议的股东所持有表决权的股份总数（股） | 226,347,312 | | 3、出席会议的股东所持有表决权股份数占公司有表决权股 | 50.40 ...

会议召开时间：2025年5月16日（星期五）16:00-17:00 会 议 召 开 地 点 ： 上 海 证 券 报 · 中 国 证 券 网 路 演 中 心 （https://roadshow.cnstock.com/） 会议召开方式：网络文字互动 证券代码：605167 证券简称：利柏特 公告编号：2025-015 江苏利柏特股份有限公司 关于召开 2024 年度业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： 投资者可于2025年5月15日（星期四）15:00前将需要了解的情况和相关 问题通过电子邮件的形式发送至公司投资者关系邮箱：investor@cnlbt.com。公 司将会在说明会上对投资者普遍关注的问题进行回答。 四、投资者参加方式 1、投资者可于 2025 年 5 月 16 日（星期五）16:00-17:00 登录上海证券报·中 国证券网路演中心（https://roadshow.cnstock.com/）在线参与，公司将及时 回答投资者的问题。 2、投资者可于 2025 年 5 月 ...

证券代码：605167 证券简称：利柏特 江苏利柏特股份有限公司 Jiangsu Libert INC. 2024 年年度股东会 会议资料 二〇二五年五月 江苏利柏特股份有限公司 2024 年年度股东会会议资料 江苏利柏特股份有限公司 2024 年年度股东会会议资料目录 | 2024 | | 年年度股东会会议须知 2 | | | --- | --- | --- | --- | | 2024 | | 年年度股东会会议议程 4 | | | 议案一： | | | | | 关于 | 2024 | 年度董事会工作报告的议案 | 6 | | 议案二： | | | | | 关于 | 2024 | 年度监事会工作报告的议案 | 11 | | 议案三： | | | | | 关于 | 2024 | 年度独立董事述职报告的议案 | 15 | | 议案四： | | | | | 关于 | 2024 | 年度财务决算报告的议案 | 16 | | 议案五： | | | | | 关于 | 2024 | 年年度报告及其摘要的议案 | 20 | | 议案六： | | | | | 关于 | 2024 | 年年度利润分配方案的议案 | 21 | | ...

Core Insights - The company achieved a revenue of 3.493 billion yuan in 2024, representing a year-on-year growth of 7.72%, while net profit attributable to shareholders reached 240 million yuan, up 26.45% year-on-year [1][2] - In Q1 2025, the company reported a revenue of 668 million yuan, a slight increase of 1.45% year-on-year, but net profit attributable to shareholders decreased by 8.07% [1][2] Financial Performance - The gross margin for 2024 was 16.09%, an increase of 1.55 percentage points year-on-year, primarily due to a shift in revenue structure with industrial module design and manufacturing revenue growing by 46.36% [2][3] - The company's net profit margin for 2024 was 6.89%, up 1.02 percentage points year-on-year, while the net profit margin after deducting non-recurring items was 6.55%, an increase of 0.92 percentage points [3] Cash Flow and Orders - The company reported a net cash inflow from operating activities of 415 million yuan for the full year 2024, an increase of 64 million yuan year-on-year, with a cash collection ratio of 95.44% [4] - As of September 2024, the company had a backlog of orders amounting to approximately 4.881 billion yuan, with an estimated conversion rate for Q4 2024 orders ranging from 60.94% to 92.48% [4] Investment and Expansion - The company plans to use funds raised from convertible bonds for a large industrial module manufacturing project, aimed at enhancing its capacity to undertake larger scale projects in sectors such as petrochemicals and nuclear power [4]

Investment Rating - The investment rating for the company is "Buy" and is maintained [11] Core Views - The company achieved a revenue of 3.493 billion yuan in 2024, representing a year-on-year growth of 7.72%. The net profit attributable to shareholders was 240 million yuan, up 26.45% year-on-year. The net profit after deducting non-recurring items was 229 million yuan, an increase of 25.25% year-on-year. In Q1 2025, the company reported a revenue of 668 million yuan, a year-on-year increase of 1.45%, while the net profit attributable to shareholders decreased by 8.07% to 36 million yuan [2][8] Financial Performance Summary - In 2024, the company benefited from an increase in gross profit margin to 16.09%, up 1.55 percentage points year-on-year, primarily due to a 46.36% increase in revenue from industrial module design and manufacturing, while engineering service revenue grew only by 0.73%. The gross profit margin for Q1 2025 was 12.33%, a decrease of 0.70 percentage points year-on-year [14] - The company reported a net cash inflow from operating activities of 415 million yuan for the year, an increase of 64 million yuan year-on-year, with a cash collection ratio of 95.44%, up 0.17 percentage points [14] - As of September 2024, the company had a backlog of orders amounting to approximately 4.881 billion yuan, with an estimated conversion rate for Q4 2024 orders ranging from 60.94% to 92.48% [14] Growth and Expansion - The company plans to use the funds raised from convertible bonds for the construction of a new large-scale industrial module manufacturing project, which is expected to enhance its capacity to undertake larger projects in the petrochemical, oil and gas energy, and nuclear power sectors [14]

Market Overview - The Shanghai Composite Index is at 3305.11 points, above the annual line, with an increase of 0.80% [1] - The total trading volume of A-shares is 646.819 billion yuan [1] Stocks Breaking Annual Line - A total of 233 A-shares have surpassed the annual line today [1] - Notable stocks with significant deviation rates include: - Jinkai Biological Science and Technology (10.11%) - Disen Power (9.84%) - Hanbo High-tech (8.84%) [1] Stock Performance Details - The top stocks with their respective performance metrics are as follows: - Jinkai Biological: Price increased by 10.32%, turnover rate 13.55%, latest price 33.02 yuan [1] - Disen Power: Price increased by 10.04%, turnover rate 1.77%, latest price 4.93 yuan [1] - Hanbo High-tech: Price increased by 9.42%, turnover rate 3.54%, latest price 15.33 yuan [1] - Other notable stocks include: - Jiashitang (9.97%, 3.57%, 13.13 yuan) - Sanmu Group (9.94%, 7.78%, 3.54 yuan) [1] Additional Stocks with Minor Deviations - Stocks with smaller deviation rates that have just crossed the annual line include: - Yongqing Environmental Protection - Dongjian Technology - Aishide [1]

Investment Rating - The report maintains a "Buy" rating for the company, with a target price not specified [7]. Core Views - The company's overall profitability remains robust, with a slight growth in non-recurring profit in Q1, driven by a decrease in expense ratio. The long-term development prospects are viewed positively [1]. - Revenue from modular design and manufacturing is rapidly increasing, contributing to further improvements in gross margin. The company expects significant growth in both domestic and international sales [2]. - The company has issued convertible bonds to fund a large industrial module project, which is anticipated to enhance manufacturing capabilities and efficiency [4]. Summary by Sections Financial Performance - In Q1, the company achieved revenue of 668 million, a year-on-year increase of 1.45%, with a net profit attributable to the parent company of 36 million, down 8.07%. The non-recurring net profit was 33 million, up 5.71% [1]. - For 2024, projected revenue is 3.493 billion, a year-on-year increase of 7.72%, with a net profit of 240 million, up 26.45% [1][5]. - The company’s gross margin for 2024 is expected to be 16.1%, an increase of 1.55 percentage points year-on-year [2]. Cost and Cash Flow - The expense ratio for 2024 is projected at 7.18%, an increase of 0.89 percentage points year-on-year. The net profit margin is expected to be 6.89% [3]. - The company’s cash flow from operations (CFO) for 2024 is projected at 415 million, an increase of 64 million year-on-year, indicating a strong cash flow situation [3]. Market and Project Developments - The company is focusing on expanding its capabilities in the nuclear power module sector, with a total investment of 1.29 billion for the new manufacturing project [4]. - The company has secured a contract for a module construction project worth 226 million, showcasing its competitive advantage in the modular manufacturing and engineering services sector [4].